Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease.

Andrea C CowanNivethika JeyakumarYuguang KangStephanie N DixonAmit X GargKyla NaylorMatthew A WeirKristin K Clemens

Published in: Clinical journal of the American Society of Nephrology : CJASN (2022)

In this cohort study of older adults, starting a SGLT2 inhibitor versus DPP-4 inhibitor was not associated with a higher risk of skeletal fracture, regardless of eGFR.

Keyphrases

small cell lung cancer
physical activity
hip fracture
epidermal growth factor receptor
tyrosine kinase